Pfizer and BioNTech have submitted new temperature data to the U.S. health regulator that they said could allow their COVID-19 vaccine to be stored in pharmacy freezers at temperatures between –25 C and –15 C for up to two weeks.
Pfizer, BioNTech apply to store COVID-19 vaccine at warmer temperatures
